BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22342815)

  • 1. Weight gain increases human aromatase expression in mammary gland.
    Chen D; Zhao H; Coon JS; Ono M; Pearson EK; Bulun SE
    Mol Cell Endocrinol; 2012 May; 355(1):114-20. PubMed ID: 22342815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice.
    Zhao H; Pearson EK; Brooks DC; Coon JS; Chen D; Demura M; Zhang M; Clevenger CV; Xu X; Veenstra TD; Chatterton RT; DeMayo FJ; Bulun SE
    Endocrinology; 2012 Jun; 153(6):2701-13. PubMed ID: 22508516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen Protects against Obesity-Induced Mammary Gland Inflammation in Mice.
    Bhardwaj P; Du B; Zhou XK; Sue E; Giri D; Harbus MD; Falcone DJ; Hudis CA; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2015 Aug; 8(8):751-9. PubMed ID: 26038116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.
    Bulun SE; Sebastian S; Takayama K; Suzuki T; Sasano H; Shozu M
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):219-24. PubMed ID: 14623514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional control of local estrogen formation by aromatase in the breast.
    To SQ; Knower KC; Cheung V; Simpson ER; Clyne CD
    J Steroid Biochem Mol Biol; 2015 Jan; 145():179-86. PubMed ID: 24846828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
    Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
    J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
    Rubin GL; Zhao Y; Kalus AM; Simpson ER
    Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organization of the human aromatase p450 (CYP19) gene.
    Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
    Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase expression and regulation in breast and endometrial cancer.
    Zhao H; Zhou L; Shangguan AJ; Bulun SE
    J Mol Endocrinol; 2016 Jul; 57(1):R19-33. PubMed ID: 27067638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
    Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
    Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
    Tekmal RR; Kirma N; Gill K; Fowler K
    Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 promotes mammary adipose tissue inflammation, local estrogen biosynthesis, and carcinogenesis in high-sugar/fat diet treated mice.
    Gonçalves RM; Delgobo M; Agnes JP; das Neves RN; Falchetti M; Casagrande T; Garcia APV; Vieira TC; Somensi N; Bruxel MA; Mendes DAGB; Rafacho A; Báfica A; Gelain DP; Moreira JCF; Cassali GD; Bishop AJR; Zanotto-Filho A
    Cancer Lett; 2021 Apr; 502():44-57. PubMed ID: 33429006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-10 suppresses TNF-α-induced expression of human aromatase gene in mammary adipose tissue.
    Martínez-Chacón G; Brown KA; Docanto MM; Kumar H; Salminen S; Saarinen N; Mäkelä S
    FASEB J; 2018 Jun; 32(6):3361-3370. PubMed ID: 29401621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells.
    Ghosh S; Choudary A; Ghosh S; Musi N; Hu Y; Li R
    Mol Endocrinol; 2009 May; 23(5):662-70. PubMed ID: 19221050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.
    Chen D; Reierstad S; Fang F; Bulun SE
    Mol Endocrinol; 2011 May; 25(5):767-75. PubMed ID: 21393445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.
    Lu M; Chen D; Lin Z; Reierstad S; Trauernicht AM; Boyer TG; Bulun SE
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4514-9. PubMed ID: 16940443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression.
    Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN
    FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.